A number of research firms have changed their ratings and price targets for Depomed (NASDAQ: DEPO):
Depomed Inc. (NASDAQ:DEPO) traded up 0.34% during trading on Friday, hitting $20.39. 285,429 shares of the stock were exchanged. Depomed Inc. has a 12-month low of $12.25 and a 12-month high of $27.02. The stock’s 50-day moving average price is $22.66 and its 200-day moving average price is $21.05. The firm’s market cap is $1.26 billion.
Depomed (NASDAQ:DEPO) last issued its earnings results on Monday, November 7th. The specialty pharmaceutical company reported $0.28 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.35 by $0.07. Depomed had a negative net margin of 16.93% and a negative return on equity of 7.49%. The firm earned $111 million during the quarter, compared to analyst estimates of $127.22 million. During the same quarter in the prior year, the firm posted $0.33 EPS. The firm’s revenue for the quarter was up 5.3% on a year-over-year basis. On average, equities analysts expect that Depomed Inc. will post $1.04 EPS for the current year.